Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Clovis Oncology, Inc. (NASDAQ: CLVS).

Full DD Report for CLVS

You must become a subscriber to view this report.


Recent News from (NASDAQ: CLVS)

Clovis Oncology Announces Second U.S. Patent Issued in Rucaparib High Dosage Strength Tablet Patent Family with Expiration in 2035
• Claims cover methods of treating cancer with all commercial dosage strengths of Rubraca® • This will be the 11th Orange Book-listed patent for Rubraca Clovis Oncology , Inc. (NASDAQ:CLVS) announced today that the United States Patent and Trademark Office iss...
Source: Business Wire
Date: November, 20 2018 08:07
Clovis Oncology to Present at the Credit Suisse 27th Annual Healthcare Conference
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Patrick J. Mahaffy, Chief Executive Officer and President, will present at the 27 th Annual Healthcare Conference on Wednesday, November 14, 2018 at 11:30 AM Mountain Time. The conference will be held at the Phoenician in Scottsdale....
Source: Business Wire
Date: November, 07 2018 08:00
Big Biotech May Be After These Technologies
HENDERSON, NV / ACCESSWIRE / November 6, 2018 / Big biotech stock buybacks "have destroyed more than $12 billion in value, and generated no positive return in total, at least as a portfolio investment," Leerink analyst Geoffry Porges recently said in a Marketwatch report. Big biotech has sp...
Source: ACCESSWIRE IA
Date: November, 06 2018 10:30
Fitbit, Clovis Oncology and FreightCar America among midday movers (11.01.2018)
More news on: SELLAS Life Sciences Group, Inc., Globus Maritime Ltd., FormFactor, Inc., Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: November, 01 2018 12:39
Today's Research Reports on Stocks to Watch: Strongbridge Biopharma and Clovis Oncology
NEW YORK, NY / ACCESSWIRE / November 1, 2018 / Strongbridge Biopharma was one of the biggest winners in the biotech arena yesterday after announcing a deal with Denmark’s Novo Nordisk. Shares of Clovis Oncology were in the red after reporting third quarter results. RDI Initiates Cov...
Source: ACCESSWIRE IA
Date: November, 01 2018 07:50
Healthcare & Tech leads midday movers (10/31/2018)
More news on: Strongbridge Biopharma, AEterna Zentaris, Inc., Accuray Incorporated, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: October, 31 2018 12:39
Weaker earnings lead stocks lower premarket
McDermott International (NYSE: MDR )  -29%  on Q3 earnings . More news on: McDermott International, Inc., 3D Systems Corp., Owens & Minor Inc., Stocks on the move, , Top stock market news, Read more ...
Source: SeekingAlpha
Date: October, 31 2018 09:15
Clovis Oncology, Inc. (CLVS) CEO Patrick Mahaffy on Q3 2018 Results - Earnings Call Transcript
Clovis Oncology (CLVS) Q3 2018 Results Earnings Conference Call October 30, 2018, 04:30 PM ET Executives Breanna Burkart - Vice President of Investor Relations Patrick Mahaffy - President and CEO Dan Muehl - SVP of Finance and Principal Finance and Accounting Officer Analysts ...
Source: SeekingAlpha
Date: October, 30 2018 21:09
Earnings-related companies top list of after hours movers (10/30/2018)
Top Gainers:   KMPH   +14.2% . ARNC   +7.3% . HABT   +7.1% . ARNC   +7.1% . AINV   +6.2% . More news on: KemPharm, Arconic Inc, The Habit Restaurants, Stocks on the move, , News on ETFs, Read more ...
Source: SeekingAlpha
Date: October, 30 2018 17:40
Clovis Oncology Q3 Rubraca sales up 36%, but below consensus; shares down 19% after hours
Clovis Oncology (NASDAQ: CLVS ) Q3 results ($M): Rubraca sales: 22.8 (+35.7%). More news on: Clovis Oncology, Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Source: SeekingAlpha
Date: October, 30 2018 16:40

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-0835.1335.1935.674434.70325,509
2018-05-1752.0052.0153.9051.251,537,973
2017-02-0362.6464.2964.4861.502,813,363
2017-02-0265.5565.3666.3864.75011,319,405
2017-02-0165.0065.1867.1663.352,332,009

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-14623,8971,280,75348.7133Short
2018-12-13684,8451,158,95259.0917Short
2018-12-12232,007550,12542.1735Short
2018-12-11521,968873,00859.7896Short
2018-12-10603,274971,17362.1181Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CLVS.


About Clovis Oncology, Inc. (NASDAQ: CLVS)

Logo for Clovis Oncology, Inc. (NASDAQ: CLVS)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: CLVS)

      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: May, 09 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 08 2018
      Official notification to shareholders of matters to be brought to a vote (Proxy)
      Filing Type: DEF 14AFiling Source: edgar
      Filing Date: April, 27 2018
      Additional proxy soliciting materials - definitive
      Filing Type: DEFA14AFiling Source: edgar
      Filing Date: April, 27 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: April, 19 2018
      Free Writing Prospectus
      Filing Type: FWPFiling Source: edgar
      Filing Date: April, 17 2018
      Free Writing Prospectus
      Filing Type: FWPFiling Source: edgar
      Filing Date: April, 17 2018
      Prospectus filed under Rule 424(b)(5)
      Filing Type: 424B5Filing Source: edgar
      Filing Date: April, 17 2018
      Prospectus filed under Rule 424(b)(5)
      Filing Type: 424B5Filing Source: edgar
      Filing Date: April, 17 2018
      Post-effective Amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR
      Filing Type: POSASRFiling Source: edgar
      Filing Date: April, 16 2018

       

       


      Daily Technical Chart for (NASDAQ: CLVS)

      Daily Technical Chart for (NASDAQ: CLVS)


      Stay tuned for daily updates and more on (NASDAQ: CLVS)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: CLVS)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CLVS is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of CLVS and does not buy, sell, or trade any shares of CLVS. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/